Home | Business News | Browse by Publication | F | FDA Consumer

Treatment for wet macular degeneration.

Publication: FDA Consumer
Publication Date: 01-SEP-06
Format: Online
Delivery: Immediate Online Access
Full Article Title: Treatment for wet macular degeneration.(Updates)

Article Excerpt
The FDA has approved Lucentis (ranibizumab injection) for the treatment of people with wet (neovascular) age-related macular degeneration (AMD). Lucemis is the first treatment that, when taken monthly, can maintain the vision of more than 90 percent of people with this type of AMD, studies show.

Lucentis is a new molecular entity,...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from FDA Consumer
New HIV treatment.(Updates), September 01, 2006
Curbing counterfeit drugs., September 01, 2006
New vaccine prevents cervical cancer., September 01, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.